Quantitative electroencephalographic correlates of psychosis in Alzheimer disease

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 13, Issue 3, 2000, Pages 163-170

  Edwards Lee, Terri ^a   Cook, Ian ^b   Fairbanks, Lynn ^b   Leuchter, Andrew ^b   Cummings, Jeffrey L ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DIAZEPAM; FLUOXETINE; LORAZEPAM; PSYCHOTROPIC AGENT; SERTRALINE; TACRINE; VENLAFAXINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN MAPPING; BRAIN REGION; COGNITIVE DEFECT; CORRELATION FUNCTION; DELUSION; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; FEMALE; FREQUENCY ANALYSIS; FRONTAL LOBE; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL TEST; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSIS; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; BRAIN; DELUSIONS; ELECTROENCEPHALOGRAPHY; FEMALE; HALLUCINATIONS; HUMANS; MALE; MENTAL STATUS SCHEDULE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 0033914723     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wragg RE, Jeste DV. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry 1989;146:577-87.
2. Mega M, Cummings JL, Fiorello T, Gombein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46: 130-5.
3. Levy ML, Cummings JL, Fairbanks LA, et al. Longitudinal assessment of symptoms of depression, agitation, and psychosis in 181 patients with Alzheimer's disease. Am J Psychiatry 1996;153:1438-43.
4. Trimble MR. Biological psychiatry, 2nd ed. Chichester: John Wiley & Sons, 1996.
5. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter for diagnosis and evaluation of dementia (summary statement). Neurology 1994;44:2203-5.
6. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-74.
7. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
9. Leuchter AF, Spar JE, Walter DO, Weiner H. Electroencephalographic spectra and coherence in the diagnosis of Alzheimer's-type and multi-infarct dementia. A pilot study. Arch Gen Psychiatry 1987;44:993-8.
10. Leuchter AF, Cook IA, Newton TF, et al. Regional differences in brain electrical activity in dementia: use of spectral power and spectral ratio measures. Electroencephalogr Clin Neurophysiol 1993;87: 385-93.
11. Yener GG, Leuchter AF, Jenden D, et al. Quantitative EEG in frontotemporal dementia. Clin Electroencephalogr 1996;27:61-8.
12. Lopez OL, Becker JT, Brenner RP. Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology 1991;41:906-12.
13. Lopez OL, Brenner RP, Becker JT, et al. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology 1997;48:1521-5.
14. Zubenko GS, Moossy J, Martinez AJ, et al. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol 1991;48:619-24.
15. Whitehouse PJ, Price DL, Clark AW, et al. Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 1981;10:122-6.
16. Tomlinson BE, Irving D, Blessed G. Cell loss in the locus ceruleus in senile dementia of Alzheimer type. J Neurol Sci 1981;49:419-28.
17. Palmer AM, Stratmann GC, Procter AW, Bowen DM. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann Neurol 1988;23:616-20.
18. Zweig RM, Ross CA, Hedreen JC, et al. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 1938;24:233-42.
19. Cummings JL, Kaufer D. Neuropsychiatrie aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996;47: 876-83.
20. Cummings JL, Gorman DG, Shapira J. Physostigmine ameliorates the delusions of Alzheimer's disease. Biol Psychiatry 1993;33:536-41.
21. Holschneider DP, Leuchter AF, Walton NY, et al. Changes in cortical EEG and cholinergic function in response to NGF n rats with nucleus basalis lesions. Brain Res 1997;765:228-37.